Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pierre Fabre acquisition

This article was originally published in The Rose Sheet

Executive Summary

French Pharmaceutical company forms Pierre Fabre Dermo Cosmetique USA subsidiary to acquire Genesis Pharmaceutical and C&M Pharmacal, marketers of Glytone and Wellskin skin care lines through dermatologists, firm announces Oct. 2. Acquisition is first step in Pierre Fabre's dermo cosmetic strategy in the U.S., company adds. Pierre Fabre will supplement Genesis' products with its own beginning with U.S. launch of Eau Thermale Avene, the company's main dermo cosmetic brand. New subsidiary will be headed by President Olivier Fontaine. Genesis President and CEO Leonard Mazur will retain his current position...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts